Global Classical Swine Fever Vaccines Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Classical Swine Fever Vaccines Market
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

Due to the COVID-19 pandemic, the global Classical Swine Fever Vaccines market size is estimated to be worth US$ 188.6 million in 2022 and is forecast to a readjusted size of US$ 260.1 million by 2028 with a CAGR of 5.5% during the review period. Fully considering the economic change by this health crisis, Tissue Culture Origin accounting for % of the Classical Swine Fever Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Government Tender segment is altered to an % CAGR throughout this forecast period.

The global classical swine fever vaccine market is dominated by Winsun, Merial and CAHIC, with the top three manufacturers accounting for about 60% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 50%, followed by Europe with a market share of about 25%. Tissue Culture Origin is the main type, with a share about 60%. Market Sales is the main application, which holds a share about 95%.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Source

Tissue Culture Origin

Cell Line Origin

Segment by Sales Channel

Government Tender

Market Sales

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Classical Swine Fever Vaccines market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

WINSUN

Merial

CAHIC

Chopper Biology

MSD Animal Health (Merck)

ChengDu Tecbond

Ceva

Harbin Veterinary Research Institute

Qilu Animal Health Products Factory

Ringpu Biology

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Institutul Pasteur

MVP

Tecon

TABLE OF CONTENT

1 Study Coverage
1.1 Classical Swine Fever Vaccines Product Introduction

1.2 Market by Source

1.2.1 Global Classical Swine Fever Vaccines Market Size Growth Rate by Source, 2017 VS 2021 VS 2028

1.2.2 Tissue Culture Origin

1.2.3 Cell Line Origin

1.3 Market by Sales Channel

1.3.1 Global Classical Swine Fever Vaccines Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028

1.3.2 Government Tender

1.3.3 Market Sales

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Classical Swine Fever Vaccines Sales Estimates and Forecasts 2017-2028

2.2 Global Classical Swine Fever Vaccines Revenue Estimates and Forecasts 2017-2028

2.3 Global Classical Swine Fever Vaccines Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Classical Swine Fever Vaccines Sales by Region

2.4.1 Global Classical Swine Fever Vaccines Sales by Region (2017-2022)

2.4.2 Global Sales Classical Swine Fever Vaccines by Region (2023-2028)

2.5 Global Classical Swine Fever Vaccines Revenue by Region

2.5.1 Global Classical Swine Fever Vaccines Revenue by Region (2017-2022)

2.5.2 Global Classical Swine Fever Vaccines Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Classical Swine Fever Vaccines Sales by Manufacturers

3.1.1 Global Top Classical Swine Fever Vaccines Manufacturers by Sales (2017-2022)

3.1.2 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Classical Swine Fever Vaccines in 2021

3.2 Global Classical Swine Fever Vaccines Revenue by Manufacturers

3.2.1 Global Classical Swine Fever Vaccines Revenue by Manufacturers (2017-2022)

3.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Classical Swine Fever Vaccines Revenue in 2021

3.3 Global Classical Swine Fever Vaccines Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Classical Swine Fever Vaccines Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Source

4.1 Global Classical Swine Fever Vaccines Sales by Source

4.1.1 Global Classical Swine Fever Vaccines Historical Sales by Source (2017-2022)

4.1.2 Global Classical Swine Fever Vaccines Forecasted Sales by Source (2023-2028)

4.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Source (2017-2028)

4.2 Global Classical Swine Fever Vaccines Revenue by Source

4.2.1 Global Classical Swine Fever Vaccines Historical Revenue by Source (2017-2022)

4.2.2 Global Classical Swine Fever Vaccines Forecasted Revenue by Source (2023-2028)

4.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2017-2028)

4.3 Global Classical Swine Fever Vaccines Price by Source

4.3.1 Global Classical Swine Fever Vaccines Price by Source (2017-2022)

4.3.2 Global Classical Swine Fever Vaccines Price Forecast by Source (2023-2028)

5 Market Size by Sales Channel

5.1 Global Classical Swine Fever Vaccines Sales by Sales Channel

5.1.1 Global Classical Swine Fever Vaccines Historical Sales by Sales Channel (2017-2022)

5.1.2 Global Classical Swine Fever Vaccines Forecasted Sales by Sales Channel (2023-2028)

5.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2017-2028)

5.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel

5.2.1 Global Classical Swine Fever Vaccines Historical Revenue by Sales Channel (2017-2022)

5.2.2 Global Classical Swine Fever Vaccines Forecasted Revenue by Sales Channel (2023-2028)

5.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2017-2028)

5.3 Global Classical Swine Fever Vaccines Price by Sales Channel

5.3.1 Global Classical Swine Fever Vaccines Price by Sales Channel (2017-2022)

5.3.2 Global Classical Swine Fever Vaccines Price Forecast by Sales Channel (2023-2028)

6 North America

6.1 North America Classical Swine Fever Vaccines Market Size by Source

6.1.1 North America Classical Swine Fever Vaccines Sales by Source (2017-2028)

6.1.2 North America Classical Swine Fever Vaccines Revenue by Source (2017-2028)

6.2 North America Classical Swine Fever Vaccines Market Size by Sales Channel

6.2.1 North America Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)

6.2.2 North America Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)

6.3 North America Classical Swine Fever Vaccines Market Size by Country

6.3.1 North America Classical Swine Fever Vaccines Sales by Country (2017-2028)

6.3.2 North America Classical Swine Fever Vaccines Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Classical Swine Fever Vaccines Market Size by Source

7.1.1 Europe Classical Swine Fever Vaccines Sales by Source (2017-2028)

7.1.2 Europe Classical Swine Fever Vaccines Revenue by Source (2017-2028)

7.2 Europe Classical Swine Fever Vaccines Market Size by Sales Channel

7.2.1 Europe Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)

7.2.2 Europe Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)

7.3 Europe Classical Swine Fever Vaccines Market Size by Country

7.3.1 Europe Classical Swine Fever Vaccines Sales by Country (2017-2028)

7.3.2 Europe Classical Swine Fever Vaccines Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Source

8.1.1 Asia Pacific Classical Swine Fever Vaccines Sales by Source (2017-2028)

8.1.2 Asia Pacific Classical Swine Fever Vaccines Revenue by Source (2017-2028)

8.2 Asia Pacific Classical Swine Fever Vaccines Market Size by Sales Channel

8.2.1 Asia Pacific Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)

8.2.2 Asia Pacific Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)

8.3 Asia Pacific Classical Swine Fever Vaccines Market Size by Region

8.3.1 Asia Pacific Classical Swine Fever Vaccines Sales by Region (2017-2028)

8.3.2 Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Classical Swine Fever Vaccines Market Size by Source

9.1.1 Latin America Classical Swine Fever Vaccines Sales by Source (2017-2028)

9.1.2 Latin America Classical Swine Fever Vaccines Revenue by Source (2017-2028)

9.2 Latin America Classical Swine Fever Vaccines Market Size by Sales Channel

9.2.1 Latin America Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)

9.2.2 Latin America Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)

9.3 Latin America Classical Swine Fever Vaccines Market Size by Country

9.3.1 Latin America Classical Swine Fever Vaccines Sales by Country (2017-2028)

9.3.2 Latin America Classical Swine Fever Vaccines Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Source

10.1.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Source (2017-2028)

10.1.2 Middle East and Africa Classical Swine Fever Vaccines Revenue by Source (2017-2028)

10.2 Middle East and Africa Classical Swine Fever Vaccines Market Size by Sales Channel

10.2.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)

10.2.2 Middle East and Africa Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)

10.3 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country

10.3.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2017-2028)

10.3.2 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 WINSUN

11.1.1 WINSUN Corporation Information

11.1.2 WINSUN Overview

11.1.3 WINSUN Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 WINSUN Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 WINSUN Recent Developments

11.2 Merial

11.2.1 Merial Corporation Information

11.2.2 Merial Overview

11.2.3 Merial Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Merial Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merial Recent Developments

11.3 CAHIC

11.3.1 CAHIC Corporation Information

11.3.2 CAHIC Overview

11.3.3 CAHIC Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 CAHIC Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 CAHIC Recent Developments

11.4 Chopper Biology

11.4.1 Chopper Biology Corporation Information

11.4.2 Chopper Biology Overview

11.4.3 Chopper Biology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Chopper Biology Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Chopper Biology Recent Developments

11.5 MSD Animal Health (Merck)

11.5.1 MSD Animal Health (Merck) Corporation Information

11.5.2 MSD Animal Health (Merck) Overview

11.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 MSD Animal Health (Merck) Recent Developments

11.6 ChengDu Tecbond

11.6.1 ChengDu Tecbond Corporation Information

11.6.2 ChengDu Tecbond Overview

11.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 ChengDu Tecbond Recent Developments

11.7 Ceva

11.7.1 Ceva Corporation Information

11.7.2 Ceva Overview

11.7.3 Ceva Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Ceva Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Ceva Recent Developments

11.8 Harbin Veterinary Research Institute

11.8.1 Harbin Veterinary Research Institute Corporation Information

11.8.2 Harbin Veterinary Research Institute Overview

11.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Harbin Veterinary Research Institute Recent Developments

11.9 Qilu Animal Health Products Factory

11.9.1 Qilu Animal Health Products Factory Corporation Information

11.9.2 Qilu Animal Health Products Factory Overview

11.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Qilu Animal Health Products Factory Recent Developments

11.10 Ringpu Biology

11.10.1 Ringpu Biology Corporation Information

11.10.2 Ringpu Biology Overview

11.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Ringpu Biology Recent Developments

11.11 DHN

11.11.1 DHN Corporation Information

11.11.2 DHN Overview

11.11.3 DHN Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 DHN Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 DHN Recent Developments

11.12 CAVAC

11.12.1 CAVAC Corporation Information

11.12.2 CAVAC Overview

11.12.3 CAVAC Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 CAVAC Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 CAVAC Recent Developments

11.13 Komipharm

11.13.1 Komipharm Corporation Information

11.13.2 Komipharm Overview

11.13.3 Komipharm Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 Komipharm Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Komipharm Recent Developments

11.14 Agrovet

11.14.1 Agrovet Corporation Information

11.14.2 Agrovet Overview

11.14.3 Agrovet Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.14.4 Agrovet Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Agrovet Recent Developments

11.15 Bioveta

11.15.1 Bioveta Corporation Information

11.15.2 Bioveta Overview

11.15.3 Bioveta Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.15.4 Bioveta Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Bioveta Recent Developments

11.16 Jinyu Bio-Technology

11.16.1 Jinyu Bio-Technology Corporation Information

11.16.2 Jinyu Bio-Technology Overview

11.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Jinyu Bio-Technology Recent Developments

11.17 Institutul Pasteur

11.17.1 Institutul Pasteur Corporation Information

11.17.2 Institutul Pasteur Overview

11.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Institutul Pasteur Recent Developments

11.18 MVP

11.18.1 MVP Corporation Information

11.18.2 MVP Overview

11.18.3 MVP Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.18.4 MVP Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 MVP Recent Developments

11.19 Tecon

11.19.1 Tecon Corporation Information

11.19.2 Tecon Overview

11.19.3 Tecon Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.19.4 Tecon Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.19.5 Tecon Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Classical Swine Fever Vaccines Industry Chain Analysis

12.2 Classical Swine Fever Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Classical Swine Fever Vaccines Production Mode & Process

12.4 Classical Swine Fever Vaccines Sales and Marketing

12.4.1 Classical Swine Fever Vaccines Sales Channels

12.4.2 Classical Swine Fever Vaccines Distributors

12.5 Classical Swine Fever Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Classical Swine Fever Vaccines Industry Trends

13.2 Classical Swine Fever Vaccines Market Drivers

13.3 Classical Swine Fever Vaccines Market Challenges

13.4 Classical Swine Fever Vaccines Market Restraints

14 Key Findings in The Global Classical Swine Fever Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample